Index No | International Chemical Identification | EC No | CAS No | Classification | Labelling |
Specific Conc. Limits,
M — Factors
Notes
Hazard Class and Category Code(s) | Hazard statement Code(s) | Pictogram, Signal Word Code(s) | Hazard statement Code(s) | Suppl. Hazard statement Code(s)
031-001-00-4 | gallium arsenide | 215-114-8 | 1303-00-0 | Carc. 1B | H350 | GHS08 | H350 | | |
STOT RE 1 | H372 (respiratory and haematopoietic systems) | Dgr | H372 (respiratory and haematopoietic systems)
050-025-00-6 | trichloromethylstannane | 213-608-8 | 993-16-8 | Repr. 2 | H361d |
GHS08
Wng
H361d | | |
050-026-00-1 | 2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate | 260-828-5 | 57583-34-3 | Repr. 2 | H361d |
GHS08
Wng
H361d | | |
050-027-00-7 | 2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate | 239-622-4 | 15571-58-1 | Repr. 1B | H360D |
GHS08
Dgr
H360D | | |
601-087-00-3 | 2,4,4-trimethylpentene | 246-690-9 | 25167-70-8 | Flam. Liq. 2 | H225 | GHS02 | H225 | | | D
Asp. Tox. 1 | H304 | GHS07 | H304
STOT SE 3 | H336 |
GHS08
Dgr
H336
606-145-00-1 |
sulcotrione (ISO);
2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione
99105-77-8 | Repr. 2 | H361d | GHS08 | H361d | |
M = 1
M = 10
STOT RE 2 | H373 (kidneys) | GHS07 | H373 (kidneys)
Skin Sens. 1A | H317 | GHS09 | H317
Aquatic Acute 1 | H400 | Wng |
Aquatic Chronic 1 | H410 | | H410
607-699-00-7 |
bifenthrin (ISO);
(2-methylbiphenyl-3-yl)methyl rel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate
82657-04-3 | Carc. 2 | H351 | GHS06 | H351 | |
M = 10000
M = 100000
Acute Tox. 3 | H331 | GHS08 | H331
Acute Tox. 2 | H300 | GHS09 | H300
STOT RE 1 | H372 (nervous system) | Dgr | H372 (nervous system)
Skin Sens. 1B | H317 | | H317
Aquatic Acute 1 | H400 | |
Aquatic Chronic 1 | H410 | | H410
607-700-00-0 |
indoxacarb (ISO);
methyl (4aS)-7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [1]
173584-44-6 [1] | Acute Tox. 3 | H301 | GHS06 | H301 | |
M = 1
M = 1
Acute Tox. 4 | H332 | GHS08 | H332
STOT RE 1 | H372 (blood, nervous system, heart) | GHS09 | H372 (blood, nervous system, heart)
Skin Sens. 1B | H317 | Dgr | H317
Aquatic Acute 1 | H400 | |
Aquatic Chronic 1 | H410 | | H410
reaction mass of (S)- Indoxacarb and (R)- Indoxacarb 75:25;
methyl 7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [2]
144171-61-9 [2] | | | |
607-702-00-1 | dihexyl phthalate | 201-559-5 | 84-75-3 | Repr. 1B | H360FD |
GHS08
Dgr
H360FD | | |
607-703-00-7 | ammoniumpentadeca- fluorooctanoate | 223-320-4 | 3825-26-1 | Carc. 2 | H351 | GHS08 | H351 | | |
Repr. 1B | H360D | GHS07 | H360D
Lact. | H362 | GHS05 | H362
Acute Tox. 4 | H332 | Dgr | H332
Acute Tox. 4 | H302 | | H302
STOT RE 1 | H372 (liver) | | H372 (liver)
Eye Dam.1 | H318 | | H318
607-704-00-2 | perfluorooctanoic acid | 206-397-9 | 335-67-1 | Carc. 2 | H351 | GHS08 | H351 | | |
Repr. 1B | H360D | GHS07 | H360D
Lact. | H362 | GHS05 | H362
Acute Tox. 4 | H332 | Dgr | H332
Acute Tox. 4 | H302 | | H302
STOT RE 1 | H372 (liver) | | H372 (liver)
Eye Dam. 1 | H318 | | H318
612-282-00-8 | octadecylamine | 204-695-3 | 124-30-1 | Asp. Tox. 1 | H304 | GHS05 | H304 | |
M = 10
M = 10
STOT RE 2 | H373 (gastro-intestinal tract, liver, immune system) | GHS08 | H373 (gastro-intestinal tract, liver, immune system)
Skin Irrit. 2 | H315 | GHS09 | H315
Eye Dam. 1 | H318 | Dgr | H318
Aquatic Acute 1 | H400 | |
Aquatic Chronic 1 | H410 | | H410
612-283-00-3 | (Z)-octadec-9-enylamine | 204-015-5 | 112-90-3 | Acute Tox. 4 | H302 | GHS05 | H302 | |
M = 10
M = 10
Asp Tox. 1 | H304 | GHS07 | H304
STOT SE 3 | H335 | GHS08 | H335
STOT RE 2 | H373 (gastro-intestinal tract, liver, immune system) | GHS09 | H373 (gastro-intestinal tract, liver, immune system)
Skin Corr. 1B | H314 | Dgr | H314
Aquatic Acute 1 | H400 | |
Aquatic Chronic 1 | H410 | | H410
612-284-00-9 | amines, hydrogenated tallow alkyl | 262-976-6 | 61788-45-2 | Asp Tox. 1 | H304 | GHS08 | H304 | |
M = 10
M = 10
STOT RE 2 | H373 (gastro-intestinal tract, liver, immune system) | GHS05 | H373 (gastro-intestinal tract, liver, immune system)
Skin Irrit. 2 | H315 | GHS09 | H315
Eye Dam. 1 | H318 | Dgr | H318
Aquatic Acute 1 | H400 | |
Aquatic Chronic 1 | H410 | | H410
612-285-00-4 | amines, coco alkyl | 262-977-1 | 61788-46-3 | Acute Tox. 4 | H302 | GHS05 | H302 | |
M = 10
M = 10
Asp. Tox. 1 | H304 | GHS07 | H304
STOT SE 3 | H335 | GHS08 | H335
STOT RE 2 | H373 (gastro-intestinal tract, liver, immune system) | GHS09 | H373 (gastro-intestinal tract, liver, immune system)
Skin Corr. 1B | H314 | Dgr | H314
Aquatic Acute 1 | H400 | |
Aquatic Chronic 1 | H410 | | H410
612-286-00-X | amines, tallow alkyl | 263-125-1 | 61790-33-8 | Acute Tox. 4 | H302 | GHS05 | H302 | |
M = 10
M = 10
Asp. Tox. 1 | H304 | GHS07 | H304
STOT RE 2 | H373 (gastro-intestinal tract, liver, immune system) | GHS08 | H373 (gastro-intestinal tract, liver, immune system)
Skin Corr. 1B | H314 | GHS09 | H314
Aquatic Acute 1 | H400 | Dgr |
Aquatic Chronic 1 | H410 | | H410
616-206-00-4 |
flufenoxuron (ISO);
1-(4-(2-cloro-α,α,α-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea
417-680-3 | 101463-69-8 | Lact. | H362 | GHS09 | H362 | |
M = 10000
M = 10000
Aquatic Acute 1 | H400 | Wng |
Aquatic Chronic 1 | H410 | | H410
616-207-00-X | polyhexamethylene biguanide hydrochloride | | 27083-27-8 or 32289-58-0 | Carc. 2 | H351 | GHS05 | H351 | |
M = 10
M = 10
Acute Tox. 4 | H302 | GHS07 | H302
STOT RE 1 | H372 (respiratory tract) (inhalation) | GHS08 | H372 (respiratory tract) (inhalation)
Eye Dam. 1 | H318 | GHS09 | H318
Skin Sens. 1B | H317 | Dgr | H317
Aquatic Acute 1 | H400 | |
Aquatic Chronic 1 | H410 | | H410
616-208-00-5 |
N-ethyl-2-pyrrolidone;
1-ethylpyrrolidin-2-one
220-250-6 | 2687-91-4 | Repr. 1B | H360D |
GHS08
Dgr
H360D | | |
616-209-00-0 |
amidosulfuron (ISO);
3-(4,6-dimethoxypyrimidin-2-yl)-1-((N-methyl-N-methylsulfonylamino)sulfonyl)urea
407-380-0 | 120923-37-7 | Aquatic Acute 1 | H400 | GHS09 | | |
M = 100
M = 100
Aquatic Chronic 1 | H410 | Wng | H410
616-210-00-6 |
tebufenpyrad (ISO);
N-(4-tertbutylbenzyl)-4-chloro-3-ethyl-1-methyl-1Hpyrazole-5- carboxamide
119168-77-3 | Acute Tox. 3 | H301 | GHS06 | H301 | |
M = 10
M = 10
Acute Tox. 4 | H332 | GHS08 | H332
STOT RE 2 | H373 (gastro-intestinal tract) (Oral) | GHS09 | H373 (gastro-intestinal tract) (Oral)
Skin Sens. 1B | H317 | Dgr | H317
Aquatic Acute 1 | H400 | |
Aquatic Chronic 1 | H410 | | H410
616-211-00-1 |
proquinazid (ISO);
6-iodo-2-propoxy-3-propylquinazolin-4(3H)-one
189278-12-4 | Carc. 2 | H351 | GHS08 | H351 | |
M = 1
M = 10
Aquatic Acute 1 | H400 | GHS09 |
Aquatic Chronic 1 | H410 | Wng | H410